|
|
||||||||||||||||||||||||||||||||||||
![]() Alumnus, Researcher Gives SNC Talk on Biotechnology Issues November 2, 2001
A renowned researcher and enterpreneur, Dr. Schimmel has focused his research on decoding genetic information and interpreting the universal code. Among Dr. Schimmel's research interests are autism and other conditions primarily as they impact children. Having a longstanding interest in the applications of basic biomedical research to human health, Dr. Schimmel is a co-founder of three publicly traded biotechnology companies. A member of the National Academy of Sciences, the American Society for Biochemistry and Molecular Biology, and an elected fellow of the American Association for Advancement of Science, Dr. Schimmel has been named a recipient of the Biophysical Society's Emily M. Gray Award, for his "significant contributions to teaching and education in biophysics." He was also an Honorary Degree recipient during the 1996 OWU Commencement. He served as an editorial board member of ten different scientific journals and is the author and co-author of over 260 publications and scientific papers. Paul Schimmel is a 1962 graduate of Ohio Wesleyan University and holds a Ph.D. from the Massachusetts Institute of Technology, where he taught from 1967 to 1997 with his most recent position being the John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics. The Sagan National Colloquium is in its 16th year at OWU. Lectures are free of charge and open to the public. For more information, call the Office of University Communications at 740-368-3335 or visit snc.owu.edu. |
|||||||||||||||||||||||||||||||||||||
| Copyright © Ohio Wesleyan University. All rights reserved. | 61 S. Sandusky St., Delaware, Ohio, 43015 | Phone: (800) 922-8953 or (740) 368-2000 |